EICHORCondition: Hypogonadism · Cardiovascular Diseases · Sponsor: AbbVie
This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Wright Clinical Research, LLC /ID# 210864 | Alabaster, Alabama, United States | — |
| Simon-Williamson Clinic /ID# 210249 | Birmingham, Alabama, United States | — |
| Alabama Clinical Therapeutics /ID# 202982 | Birmingham, Alabama, United States | — |
| Cahaba Research, Inc. /ID# 167928 | Birmingham, Alabama, United States | — |
| Atlanta VAHCS /ID# 170318 | Decatur, Alabama, United States | — |
| G & L Research, LLC /ID# 170365 | Foley, Alabama, United States | — |
| Fundamental Research /ID# 170504 | Gulf Shores, Alabama, United States | — |
| Urology Centers of Alabama /ID# 206197 | Homewood, Alabama, United States | — |
| Longwood Research /ID# 201754 | Huntsville, Alabama, United States | — |
| Medical Affiliated Research Center, Inc. /ID# 170569 | Huntsville, Alabama, United States | — |
| Mostellar Medical Center /ID# 170329 | Mobile, Alabama, United States | — |
| Terence T. Hart, MD /ID# 201561 | Tuscumbia, Alabama, United States | — |
+ 372 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03518034